In human tumor slice cultures (TSCs) from patients with CRLM, the addition of anti-IL-10 neutralizing antibodies significantly increased the proportion of CD8+ T cells and HLA-DR expression on macrophages, resulting in a 1.8-fold increase in T-cell-mediated tumor cell killing. This evidence concerns the gene IL10 and neoplasm.